Matches in Nanopublications for { ?s ?p "[Mesothelin (MSLN) and cancer antigen125/mucin 16 (CA125/MUC16) are potential biomarkers for pancreatic cancer (PC) that are co-overexpressed at the invading edges of PC tissues, and their expression correlates with poor survival rates.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- NP962790.RAY0IOaHMAxZ8i_FaxVgdOEUxDg2-x0fYEBUCeANrmC5A130_assertion description "[Mesothelin (MSLN) and cancer antigen125/mucin 16 (CA125/MUC16) are potential biomarkers for pancreatic cancer (PC) that are co-overexpressed at the invading edges of PC tissues, and their expression correlates with poor survival rates.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP962790.RAY0IOaHMAxZ8i_FaxVgdOEUxDg2-x0fYEBUCeANrmC5A130_provenance.
- assertion description "[Mesothelin (MSLN) and cancer antigen125/mucin 16 (CA125/MUC16) are potential biomarkers for pancreatic cancer (PC) that are co-overexpressed at the invading edges of PC tissues, and their expression correlates with poor survival rates.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Mesothelin (MSLN) and cancer antigen125/mucin 16 (CA125/MUC16) are potential biomarkers for pancreatic cancer (PC) that are co-overexpressed at the invading edges of PC tissues, and their expression correlates with poor survival rates.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1079493.RAA0yH9lM9MFSobqKQfpZG4IYSuvLLnWWy4q7eGQZgXkU130_assertion description "[Mesothelin (MSLN) and cancer antigen125/mucin 16 (CA125/MUC16) are potential biomarkers for pancreatic cancer (PC) that are co-overexpressed at the invading edges of PC tissues, and their expression correlates with poor survival rates.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1079493.RAA0yH9lM9MFSobqKQfpZG4IYSuvLLnWWy4q7eGQZgXkU130_provenance.
- NP1079501.RAQQi2PQrjFhPX62NyLMb6tO_5hhTucOwVZwHmYHYBggs130_assertion description "[Mesothelin (MSLN) and cancer antigen125/mucin 16 (CA125/MUC16) are potential biomarkers for pancreatic cancer (PC) that are co-overexpressed at the invading edges of PC tissues, and their expression correlates with poor survival rates.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1079501.RAQQi2PQrjFhPX62NyLMb6tO_5hhTucOwVZwHmYHYBggs130_provenance.
- NP542823.RACTdwGNDhOUi_AOytPXiumLVtwN4MXNuMlCGBIQsHuSY130_assertion description "[Mesothelin (MSLN) and cancer antigen125/mucin 16 (CA125/MUC16) are potential biomarkers for pancreatic cancer (PC) that are co-overexpressed at the invading edges of PC tissues, and their expression correlates with poor survival rates.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP542823.RACTdwGNDhOUi_AOytPXiumLVtwN4MXNuMlCGBIQsHuSY130_provenance.
- NP542773.RAH1rDtcVN6cs3WJCOPY2AwrJJUmeA2xYnCtAxOG8--O8130_assertion description "[Mesothelin (MSLN) and cancer antigen125/mucin 16 (CA125/MUC16) are potential biomarkers for pancreatic cancer (PC) that are co-overexpressed at the invading edges of PC tissues, and their expression correlates with poor survival rates.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP542773.RAH1rDtcVN6cs3WJCOPY2AwrJJUmeA2xYnCtAxOG8--O8130_provenance.
- NP542701.RAytu5R2pWjWz-F0ZgBUtT1BXsld7Cyd3uD8R9zH9PSSA130_assertion description "[Mesothelin (MSLN) and cancer antigen125/mucin 16 (CA125/MUC16) are potential biomarkers for pancreatic cancer (PC) that are co-overexpressed at the invading edges of PC tissues, and their expression correlates with poor survival rates.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP542701.RAytu5R2pWjWz-F0ZgBUtT1BXsld7Cyd3uD8R9zH9PSSA130_provenance.
- NP542755.RA-mMzl6IQtWnhAH4wx2TMaKfI8ukj_njM9UqP5dEZKzM130_assertion description "[Mesothelin (MSLN) and cancer antigen125/mucin 16 (CA125/MUC16) are potential biomarkers for pancreatic cancer (PC) that are co-overexpressed at the invading edges of PC tissues, and their expression correlates with poor survival rates.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP542755.RA-mMzl6IQtWnhAH4wx2TMaKfI8ukj_njM9UqP5dEZKzM130_provenance.
- NP838783.RA4eNNmmiW-md_xC2bRKyHcy0manJ3tMvZlnre-LYeLRk130_assertion description "[Mesothelin (MSLN) and cancer antigen125/mucin 16 (CA125/MUC16) are potential biomarkers for pancreatic cancer (PC) that are co-overexpressed at the invading edges of PC tissues, and their expression correlates with poor survival rates.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP838783.RA4eNNmmiW-md_xC2bRKyHcy0manJ3tMvZlnre-LYeLRk130_provenance.
- NP838906.RA9NF9fLiFAjsHjRK9AfsL1cGILhW9EMBK9Xk9gXjADXo130_assertion description "[Mesothelin (MSLN) and cancer antigen125/mucin 16 (CA125/MUC16) are potential biomarkers for pancreatic cancer (PC) that are co-overexpressed at the invading edges of PC tissues, and their expression correlates with poor survival rates.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP838906.RA9NF9fLiFAjsHjRK9AfsL1cGILhW9EMBK9Xk9gXjADXo130_provenance.
- NP962634.RA1vEzat_Q7sUvXchIwVH0z0C5xfqhn4Af4l1oJNJiY0g130_assertion description "[Mesothelin (MSLN) and cancer antigen125/mucin 16 (CA125/MUC16) are potential biomarkers for pancreatic cancer (PC) that are co-overexpressed at the invading edges of PC tissues, and their expression correlates with poor survival rates.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP962634.RA1vEzat_Q7sUvXchIwVH0z0C5xfqhn4Af4l1oJNJiY0g130_provenance.